Home/Dobrinka Encheva

About Dobrinka Encheva

This author has not yet filled in any details.
So far Dobrinka Encheva has created 65 blog entries.

The conference will be attended by thousands of investors from around the world, but not by the Israeli institutions

The MIXII BIOMED  conference is one of the most important and leading conferences in the world in the field of life sciences, in which Israeli elite technologies will be presented in groundbreaking fields - but the Israeli institutions are apparently not interested 04.25.2017, 19:23Iki Inai Stem cells / photo: shutterstock  In May this year, the 16th [...]

By | 2017-04-27T12:48:21+00:00 April 27th, 2017|News|Comments Off on The conference will be attended by thousands of investors from around the world, but not by the Israeli institutions

Patient centricity? Pharma’s there, expert says. It’s regulators who need to catch up

by Carly Helfand | Apr 17, 2017  Treato CEO Ido Hadari says patient centricity has become "a pillar in every life sciences and healthcare company out there." YEHUD, ISRAEL—Compare pharma's ideas about patient centricity today with their ideas a few years back, and “it would probably be like landing on different planets,” according to Ido [...]

By | 2017-04-25T09:47:14+00:00 April 25th, 2017|News|Comments Off on Patient centricity? Pharma’s there, expert says. It’s regulators who need to catch up

MeMed Wins $9.2M DTRA Contract for PoC IVD to Reduce Antibiotic Misuse

Israeli firm MeMed won a contract worth up to $9.2 million from the U.S. Department of Defense (DoD) Defense Threat Reduction Agency (DTRA) to complete the development of a point-of-care in vitro diagnostic platform that can distinguish between bacterial and viral infections, and so help to prevent antibiotic misuse. MeMed’s diagnostic platform uses infection-specific immune [...]

By | 2017-04-19T13:52:52+00:00 April 19th, 2017|Blog|Comments Off on MeMed Wins $9.2M DTRA Contract for PoC IVD to Reduce Antibiotic Misuse

Mixiii Biomed 2017: Early Bird Registration

AN OPPORTUNITY NOT TO BE MISSED – TAKE AN ACTIVE ROLE REGISTER NOW (Early Bird Registration Deadline May 08, 2017) Dear Colleagues, Mixiii Biomed 2017 is generating great interest, with registration at its height. Ensure that you take advantage of the Early Bird Registration Fee (until 12:00 midnight May 8) and Register Now! For the 16th [...]

By | 2017-04-18T08:20:31+00:00 April 18th, 2017|News|0 Comments

Mixiii Biomed 2017: Only 7 days left to enter the Competition

  Only 7 days left to register to MIXiii Biomed 2017 Start-up Area and Competition by: Israel Innovation Authority! For competition details please click here. Competition registration deadline: 10 APRIL 2017 REGISTER NOW   Join the road to success and grab the chance to be an active participant at MIXiii BIOMED 2017! As a registered participant [...]

By | 2017-04-04T08:22:07+00:00 March 30th, 2017|News|0 Comments

BiolineRx buys UK co Agalimmune

BiolineRx buys UK co Agalimmune 23 Mar, 2017 14:29 Gali Weinreb BiolineRx is paying $6 million upfront for Agalimmune, which has developed a new immunotherapy solution for treating cancer. BiolineRx Ltd. (Nasdaq: BLRX); TASE:BLRX) has announced the acquisition of Agalimmune Ltd., a private UK-based company with an innovative, anti-cancer immunotherapy platform. BiolineRx is paying $6 [...]

By | 2017-03-30T12:22:25+00:00 March 30th, 2017|Blog|0 Comments

Digital Medicine: the new Israeli invention

Цифровая медицина: новые изобретения израильтян Производство электронных медицинских приборов стало одной из перспективных отраслей израильского хай-тека. В 2016 году местные фирмы, создающие их, привлекли 183 миллиона долларов в свои разработки. Это следует из отчета компании «Start-UP national central», который был представлен в преддверии открытия израильской технологической конференции Mixiii Biomed 2017. В нашей стране она будет [...]

By | 2017-03-30T10:11:31+00:00 March 30th, 2017|Blog|0 Comments

Israel digital health investments jump 30% in 2016 (English and Hebrew versions)

Some 385 companies operate in the field, with personal health tools and analytics leading deal volume BY SHOSHANNA SOLOMON March 28, 2017 A nurse uses a digital health app (Photo credit: Courtesy) Israel’s digital health sector grew significantly in 2016, both in terms of funding and in terms of the number of companies, with investments [...]

By | 2017-03-30T06:19:54+00:00 March 28th, 2017|Blog|0 Comments

Ophthalmic device co EyeYon Medical raises $6.5m

21 Mar, 2017 13:53 Globes correspondent China-based venture capital fund Rimonci Capital and co-investor Gauss Group led the financing round. Israeli ophthalmic device co EyeYon Medical founded by ophthalmologists Dr. Arie Marcovich and Dr. Daphna Ofer, and managed by CEO Nahum Ferera, has raised $6.5 million. The company, which emerged from the Val Leer incubator, [...]

By | 2017-03-22T09:30:00+00:00 March 22nd, 2017|Blog|0 Comments

IBM Watson Health To Integrate MedyMatch Technology Into Cognitive Imaging Offerings To Help Doctors Identify Head Trauma And Stroke

MedyMatch Application to Help Doctors Identify Head Trauma and Stroke MedyMatch Technology recently announced a collaboration with IBM Watson Health to bring MedyMatch’s A.I.-based clinical decision support application to imaging experts working in hospital emergency rooms and other acute care settings to help doctors identify instances of intracranial bleeding as a result of head trauma [...]

By | 2017-03-22T09:25:36+00:00 March 22nd, 2017|Blog|0 Comments